Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023;23(5):390-400.
doi: 10.2174/1566524022666220525145521.

Preclinical Evidence-based Review on Therapeutic Potential of Eugenol for the Treatment of Brain Disorders

Affiliations
Review

Preclinical Evidence-based Review on Therapeutic Potential of Eugenol for the Treatment of Brain Disorders

Ahsas Goyal et al. Curr Mol Med. 2023.

Abstract

The increasing morbidness of brain disorders and conditions, such as anxiety, stress, depression, Alzheimer's disease, Parkinson's disease, and others, have become severe. Although researchers have spent a significant amount of time examining these diseases and providing many benefits, there are still limited drugs available to treat these disorders. Eugenol, a dietary component present in numerous plants and herbs, possesses various health benefits. In various preclinical studies, eugenol has provided significant protective effects against a variety of brain disorders. Thus, including eugenol in the diet can fight various diseases and ensure a healthy life. Considering the fruitful impact of this compound, this review focuses on the brain disorders in which eugenol was used, and summarizes the beneficial properties of eugenol and its role in treating various brain diseases.

Keywords: Alzheimer’s disease; Eugenol; analgesia; brain disorders; depression; epilepsy; parkinson’s disease; stress.

PubMed Disclaimer